Celltrion Unveils Strategy Amid Series Of Milestones
Korean Company Secures Italian Bids While Launching A Product In South Korea
South Korea’s Celltrion has doubled down on its efforts in further building its pipeline, eyeing a target of 22 commercialized products by 2030 while also aiming to submit INDs for 13 novel compounds.
